<DOC>
	<DOCNO>NCT01840163</DOCNO>
	<brief_summary>This study examine impact online decision tool patient early stage invasive breast cancer . The study randomize control trial ( RCT ) 444 newly diagnose patient , recruit multiple surgical practice two SEER catchment area . Participants randomize receive either basic version decision tool ( similar exist website breast cancer information ) enhance version ( feature knowledge building component , value clarification exercise , patient activation module ) . Our hypothesis patient use enhanced version tool great knowledge test treatment option , high rate high quality ( i.e. , inform , preference-concordant ) decision , report positive appraisal decision-making process .</brief_summary>
	<brief_title>A Trial Comprehensive Breast Cancer Treatment Patient Decision Tool</brief_title>
	<detailed_description>Patients newly diagnose breast cancer face series complex decision regard locoregional systemic treatment . Currently many decision meet definition high quality decision , define one informed ( i.e. , base accurate understand treatment risk benefit ) preference-concordant ( i.e. , consistent patient ' underlying preference ) . Moreover , introduction evaluative test make decision complicate many patient . There need improve quality locoregional systemic treatment decision breast cancer patient , help patient understand role evaluative test decision process . Ensuring patient deliberate effectively decision , assert view communicate clinician likely improve overall decision preparedness satisfaction . This study focus third pillar individualize care evaluate impact innovative decision tool locoregional systemic therapy decision make newly diagnose breast cancer patient . The innovative online decision tool develop test past two year CanSORT team ( R21 CA129859 ) . Pilot data suggest tool positive impact patient knowledge decision outcomes . The goal study evaluate impact tool , enhanced collaboration Communication Dissemination Core , quality decision make locoregional systemic breast cancer treatment decision making .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Stage 12 invasive breast cancer diagnosis , DCIS Ability read English Male</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>84 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>